ArticleEpidemics2016
A generalized-growth model to characterize the early ascending phase of infectious disease outbreaks.
Article in Epidemics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
122 citing papers in PubMed.
- Results of the epidemiological measurement of endemics, epidemics, and pandemics.Infectious Disease Modelling · 2026Article
- Comparison of growth, time series, and hybrid models for HIV infectious disease incidence in adults in Saudi Arabia.BMC infectious diseases · 2026Article
- Redefining and estimating the early-phase reproduction ratio for epidemic outbreaks in spatially structured populations.PLoS computational biology · 2026Article
- An integrated framework for early detection and transmissibility assessment of emerging variants in wastewater.International journal of hygiene and environmental health · 2026Article
- Feasibility of short-term hospital mask demand forecasting using a backpropagation neural network under data scarcity.Scientific reports · 2026Article
- Modeling and Characterizing the Growth of the Texas-New Mexico Measles Outbreak of 2025.Epidemiologia (Basel, Switzerland) · 2025Article
- Ensuring Biosecurity and Research Agility for Outbreak Response: A Researcher's Perspective on the Federal Nucleic Acid Screening Framework.Applied biosafety : journal of the American Biological Safety Association · 2025Article
- Mathematical models to characterize the early phase of the COVID-19 pandemic in New Mexico, USA.Mathematical biosciences and engineering : MBE · 2025Article
- Identifying outbreak risk factors through case-controls comparisons.Communications medicine · 2025Review
- Structural and Practical Identifiability of Phenomenological Growth Models for Epidemic Forecasting.Viruses · 2025Article
- Article
- Duration of transients in outbreaks: when can infectiousness be estimated?Journal of mathematical biology · 2024Article
- Memory effects in disease modelling through kernel estimates with oscillatory time history.Journal of mathematical biology · 2024Article
- Article
- GrowthPredict: A toolbox and tutorial-based primer for fitting and forecasting growth trajectories using phenomenological growth models.Scientific reports · 2024Article
- Scale-free dynamics of COVID-19 in a Brazilian city.Applied mathematical modelling · 2023Article
- An algebraic formula, deep learning and a novel SEIR-type model for the COVID-19 pandemic.Royal Society open science · 2023Article
- The effects of city morphology on airborne transmission of COVID-19. Case study: Port Said City, Egypt.Urban climate · 2023Article
- Estimating the Importation Risk of Mpox Virus in 2022 to Hong Kong, China.Transboundary and emerging diseases · 2023Article
- Data-driven estimation of the instantaneous reproduction number and growth rates for the 2022 monkeypox outbreak in Europe.PloS one · 2023Article
62 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundA better characterization of the early growth dynamics of an epidemic is needed to dissect the important drivers of disease transmission, refine existing transmission models, and improve disease forecasts. MATERIALS AND
methodsWe introduce a 2-parameter generalized-growth model to characterize the ascending phase of an outbreak and capture epidemic profiles ranging from sub-exponential to exponential growth. We test the model against empirical outbreak data representing a variety of viral pathogens in historic and contemporary populations, and provide simulations highlighting the importance of sub-exponential growth for forecasting purposes.
resultsWe applied the generalized-growth model to 20 infectious disease outbreaks representing a range of transmission routes. We uncovered epidemic profiles ranging from very slow growth (p=0.14 for the Ebola outbreak in Bomi, Liberia (2014)) to near exponential (p>0.9 for the smallpox outbreak in Khulna (1972), and the 1918 pandemic influenza in San Francisco). The foot-and-mouth disease outbreak in Uruguay displayed a profile of slower growth while the growth pattern of the HIV/AIDS epidemic in Japan was approximately linear. The West African Ebola epidemic provided a unique opportunity to explore how growth profiles vary by geography; analysis of the largest district-level outbreaks revealed substantial growth variations (mean p=0.59, range: 0.14-0.97). The districts of Margibi in Liberia and Bombali and Bo in Sierra Leone had near-exponential growth, while the districts of Bomi in Liberia and Kenema in Sierra Leone displayed near constant incidences.
conclusionsOur findings reveal significant variation in epidemic growth patterns across different infectious disease outbreaks and highlights that sub-exponential growth is a common phenomenon, especially for pathogens that are not airborne. Sub-exponential growth profiles may result from heterogeneity in contact structures or risk groups, reactive behavior changes, or the early onset of interventions strategies, and consideration of "deceleration parameters" may be useful to refine existing mathematical transmission models and improve disease forecasts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.